Point32Health’s molecular diagnostic testing program is managed through an arrangement with our vendor partner Carelon Medical Benefits Management for certain products, and we’d like to inform providers that Carelon is implementing an update effective Aug. 1, 2025 to the way service dates are defined within that program.
In support of Point32Health and Carelon’s shared goal of providing clinically appropriate, safe, and affordable health care services, the date of service will be defined as the sample or collection date, as opposed to the date the testing begins.
For archival samples, the sample collection or retrieval date will serve as the date of service for review. In the rare circumstance that an exception is needed, providers may reach out to the Carelon genetic testing team at [email protected].
As a reminder, you may submit authorization requests online via Carelon’s portal at www.providerportal.com or by telephone at 855-574-6476. We recommend submitting requests through Carelon’s portal for its speed and convenience, with access available 24/7 to help you process requests in real time.